comprehensive -WSS

comprehensive

author：hotspot 2025-09-29 22:47:15 - browse：214

Illustration oh researchers look up at a blister pill pac. Part of the blister pack is filled with pills, while the center shows a sketch of a brain. -- biotech coverage from STAT — Mike Reddy for STAT

One by one, the companies behind Zoloft, Prozac, and Paxil soured on psychiatry.

It was the early 2000s, and as America warmed to the sounds of Sisqó and Shakira, the world’s largest pharmaceutical firms were running out of ideas to treat mental illness. Their blockbuster treatments for depression and schizophrenia had reshaped society and made billions of dollars in the process, but the old cash cows were soon to go generic. Efforts to one-up the last generation of drugs mostly resulted in incremental changes to aging medicines. And when insurance companies balked at paying brand-name prices for extended-release generics, the money dried up and the industry moved out.

“The mindset of Big Pharma in those days was one pill for millions and millions of people,” said John LaMattina, who led Pfizer’s research division from 1999 to 2007. “Everyone was looking for the next Lipitor, and when that fizzled out, there was an exodus out of psychotherapeutic areas.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： PBMs are inflating the cost of generic drugs. They must be reined in

knowledge

leisure time

WSS

Pence says 'crackpot lawyers' told Trump what he wanted to hear

People can get long Covid without testing positive for virus: Study

Sage hopes for a blockbuster in antidepressant now before FDA

Hospital at home shows how to bring innovation to health care

Amazon expands telehealth clinic nationwide

Infectious disease expert Jeanne Marrazzo assumes Fauci role

hotspot

comprehensive

hotspot

Novavax promises a turnaround & Lilly roils the obesity market

CDC says it’s too soon to assess risk posed by Covid subvariant

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Mega Millions pot grows to $1.25 billion after no winner

Walensky prepares to leave CDC — and Congress — behind

Study: Spinal cord stimulation helps patients with paralysis walk again

Virginia high school admissions case could be legal follow

Intellia plays down concerns on accidental germline transmission

Peter Hotez and the public health issue of online harassment

How the drug

entertainment

New safety details link Apellis eye drug to rare cases of blindness

Trump indictment: Who are the 'co

Meadows told special counsel he could not recall Trump ever declassifying Mar

Kellogg’s is going to war over Mexico’s nutrition label rules

Sage hopes for a blockbuster in antidepressant now before FDA

Intellia plays down concerns on accidental germline transmission

Wikipedia

knowledge

leisure time

focus